Loading organizations...
Loading organizations...
Biotechnology company developing T cell receptor-based immunotherapies.
Immunocore has raised $664.8M across 4 funding rounds.
Immunocore has raised $664.8M in total across 4 funding rounds.
Immunocore has raised $664.8M in total across 4 funding rounds.
Immunocore's investors include BlackRock, Oxford Finance, Rob Perez, Bill & Melinda Gates Foundation, CCB International, Eli Lilly and Company, JDRF T1D Fund, Rock Springs Capital, RTW Investments, Terra Magnum Capital Partners, WuXi AppTec, Adrian Howd.
Immunocore has raised $664.8M across 4 funding rounds. Most recently, it raised $175.0M Debt / Series C in January 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 13, 2021 | $175.0M Debt / Series C | BlackRock | Oxford Finance |
| Mar 18, 2020 | $130.0M Series B | Rob Perez | Bill & Melinda Gates Foundation, CCB International, Eli Lilly and Company, JDRF T1D Fund, Rock Springs Capital, RTW Investments, Terra Magnum Capital Partners, WuXi AppTec |
| Sep 17, 2017 | $40.0M Other Equity | Bill & Melinda Gates Foundation | |
| Jul 16, 2015 | $319.8M Other Equity | Eli Lilly and Company, Adrian Howd, RTW Investments, Neil Woodford |